Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Are women at greater risk from angioplasty?

22.10.2007
Research will be reported at TCT 2007, the annual scientific symposium of the Cardiovascular Research Foundation (CRF), that demonstrates that early intervention saves lives in women who have a heart attack or unstable chest pain.

Responding to media reports of recent studies that emphasized the dangers of angioplasty in women compared to men, Dr. Alexandra J. Lansky, MD, Director of the Angiographic Core Laboratory and the Women's Cardiovascular Health Initiative at the Cardiovascular Research Foundation, said that the comparison to men overshadows the true benefit to women of early intervention.

“Recent news reports suggest that women do not fare as well as men following angioplasty. However, a cumulative view of the research on this topic overwhelmingly indicates that early intervention does benefit women, and in fact, prevents death and heart attacks,” said Alexandra J. Lansky, MD, Director of the Angiographic Core Laboratory and the Women's Cardiovascular Health Initiative at the Cardiovascular Research Foundation.

A national expert on the topic of interventional cardiology in women, Dr. Lansky is the medical director of www.hearthealthywomen.org and is the lead author of the American Heart Association Statement on Interventional Cardiology in Women.

“We should be comparing interventional strategies in women to other therapies in women, in order to determine whether or not they are beneficial. The comparison to men is largely irrelevant,” Dr. Lansky said.

Dr. Lansky will be speaking on this and other topics pertaining to women’s heart health at TCT 2007 during the “Optimizing Care for Women with Cardiovascular Disease” lunchtime workshop on at Monday October 22 from 12:15-1:30 pm. TCT 2007 is being held at the Washington, DC Convention Center. Dr. Lansky is co-chairing this session with Alice Jacobs, MD former president of the American Heart Association.

In women with stable angina, a milder form of chest pain caused by narrowings in coronary arteries that are not immediately life threatening, PCI relieves chest pain symptoms better than medical therapy. In women who have more serious forms of the disease such as unstable chest pain, mild heart attack, or heart attack, PCI improves survival and reduces the chances of having a heart attack in the future.

Dr. Lansky said that women have a higher risk of bleeding complications than men, which may be caused by excessive doses of blood thinners given during the procedure; “but this is not cause enough to withhold life saving procedures from our female patients”.

However, she cautioned that recent studies comparing men to women – often looking at only a few hundred patients -- have been overemphasized and that as a result, the public has been receiving inaccurate messages.

“Everyone is confused: the media, physicians, and patients. Worse yet, women are now afraid to call for help when they need it most.”

“The message to the public should clearly be that early intervention benefits women with acute coronary syndromes (mild and severe heart attacks). Women should not delay coming to the hospital if they suspect a heart attack and should not be afraid should they need an angioplasty - it could save their life” Dr. Lansky said.

Dr. Lansky is the Director, Angiographic Core Laboratory and the Women's Cardiovascular Health Initiative at the Cardiovascular Research Foundation. For more information on the role of intervention in women’s health, visit www.hearthealthywomen.org. And, for interviews with Dr. Lansky contact David Harrison, at 410-804-1728.

About CRF and TCT

The Cardiovascular Research Foundation (CRF) in New York City is an independent, non-profit academic institution dedicated to improving the survival and quality of life of patients with cardiovascular disease through research and education. For more than 15 years, CRF has played a major role in realizing dramatic improvements in the lives of patients by establishing the safe use of new technologies and therapies in the subspecialty of interventional cardiology and endovascular medicine.

The Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, conducted by the Cardiovascular Research Foundation, is a global gathering of physicians, researchers, technologists, and industry colleagues working in the field of interventional vascular medicine. It is the world’s largest privately-run medical conference, attended by more than 10,000 participants each year and featuring the video transmission of more than 100 live patient cases from medical centers around the world. Including lectures, discussion panels, and workshops on the latest clinical findings and cutting-edge technologies, TCT educates medical professionals to ensure that the work of physicians and researchers is translated into improved patient care.

Irma Damhuis | EurekAlert!
Further information:
http://www.crf.org
http://www.hearthealthywomen.org

More articles from Event News:

nachricht ICTM Conference 2017: Production technology for turbomachine manufacturing of the future
16.11.2016 | Fraunhofer-Institut für Produktionstechnologie IPT

nachricht Innovation Day Laser Technology – Laser Additive Manufacturing
01.11.2016 | Laser Zentrum Hannover e.V.

All articles from Event News >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>